Assessment of some tools for the characterization of the human osteoarthritic cartilage proteome

Journal of Biomolecular Techniques

Volumn 16, Issue 3, 2005, Pages 256-265

  de Ceuninck, Frédéric ^a   Marcheteau, Estelle ^b   Berger, Sylvie ^b   Caliez, Audrey ^a   Dumont, Valérie ^c   Raes, Martine ^c   Anract, Philippe ^d   Leclerc, Grégory ^b   Boutin, Jean A ^b   Ferry, Gilles ^b  

^a INSTITUT DE RECHERCHES SERVIER   (France)

^b INSTITUT DE RECHERCHES SERVIER   (France)

^c UNIVERSITY OF NAMUR   (Belgium)

^d Orthopédie B ^*  (France)

Author keywords

Cartilage; Identification; Osteoarthritis; Protein; Proteome

Indexed keywords

PROTEOME;

ARTICLE; CARTILAGE; HUMAN; MASS SPECTROMETRY; METABOLISM; OSTEOARTHRITIS; PROTEIN MICROARRAY; TWO DIMENSIONAL GEL ELECTROPHORESIS;

CARTILAGE; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HUMANS; MASS SPECTROMETRY; OSTEOARTHRITIS; PROTEIN ARRAY ANALYSIS; PROTEOME;

EID: 33644852317     PISSN: 15240215     EISSN: 19434731     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Wilkins MR, Pasquali C, Appel RD, et al. From proteins to proteomes: Large scale protein identification by twodimensional electrophoresis and amino acid analysis. Bio/Technology 1996;14:61-65.
2. O'Farrell PH. High-resolution two-dimensional electrophoresis of proteins. J Biol Chem 1975;250:4007-4021.
3. Görg A, Postel W, Günther S. The current state of twodimensional electrophoresis with immobilized pH gradients. Electrophoresis 1988;9:531-546.
4. Görg A, Boguth G, Obermaier C, Posch A, Weiss W. Two-dimensional polyacrylamide gel electrophoresis with immobilized pH gradients in the first dimension (IPG-Dalt): The state of the art and the controversy of vertical versus horizontal systems. Electrophoresis 1995; 16:1079-1086.
5. Rabilloud T. Two-dimensional gel electrophoresis in proteomics: Old, old fashioned, but it still climbs up the mountains. Proteomics 2002;2:3-10.
6. Jonsson AP. Mass spectrometry for protein and peptide characterisation. Cell Mol Life Sci 2001;58:868-884.
7. Aebersold R, Mann M. Mass spectrometry-based proteomics. Nature 2003;422:198-207.
8. Dowsey AW, Dunn MJ, Yang GZ. The role of bioinformatics in two-dimensional gel electrophoresis. Proteomics 2003;3:1567-1596.
9. Langen H, Berndt P. Proteomics databases. In James P (ed.): Proteome Research: Mass Spectrometry. Berlin: Spriger-Verlag, 2000:229-257.
10. Patton WF, Schulenberg B, Steinberg TH. Twodimensional gel electrophoresis: Better than a poke in the ICAT? Curr Opin Biotechnol 2002;13:321-328.
11. Bodnar WM, Blackburn RK, Krise JM, Moseley MA. Exploiting the complementary nature of LC/MALDI/MS/MS and LC/ESI/MS/MS for increased proteome coverage. J Am Soc Mass Spectrom 2003;14:971-979.
12. Michel PE, Reymond F, Arnaud IL, Josserand J, Girault HH, Rossier JS. Protein fractionation in a multicompartment device using Off-Gel isoelectric focusing. Electrophoresis 2003;24:3-11.
13. Zhu H, Snyder M. Protein chip technology. Curr Opin Chem Biol 2003;7:55-63
14. Cutler P. Protein arrays: The current state-of-the-art. Proteomics 2003;3:3-18.
15. Gravel P, Walzer C, Aubry C, et al. New alterations of serum glycoproteins in alcoholic and cirrhotic patients revealed by high resolution two-dimensional gel electrophoresis. Biochem Biophys Res Commun 1996;220: 78-85.
16. Arnott D, Oconnell KL, King KL, Stults JT. An integrated approach to proteome analysis: Identification of proteins associated with cardiac hypertrophy. Anal Biochem 1998;258:1-18.
17. Jungblut PR, Zimny-Arndt U, Zeindl-Eberhart E, et al. Proteomics in human disease: Cancer, heart and infectious diseases. Electrophoresis 1999;20:2100-2110.
18. Edgar PF, Schonberger SJ, Dean B, et al. A comparative proteome analysis of hippocampal tissue from schizophrenic and Alzheimer's disease individuals. Mol Psychiatry 1999;4:173-178.
19. Colvis CM, Douglas-Tabor Y, Werth KB, et al. Tracking pathology with proteomics: Identification of in vivo degradation products of αB-crystallin. Electrophoresis 2000;21:2219-2227.
20. Alaiya AA, Franzen B, Auer G, Linder S. Cancer proteomics: From identification of novel markers to creation of artificial learning models for tumor classification. Electrophoresis 2000;21:1210-1217.
21. Hanash S. Disease proteomics. Nature 2003;422: 226-232.
22. Kumar S, Connor JR, Dodds RA, et al. Identification and initial characterization of 5000 expressed sequenced tags (ESTs) each from adult human normal and osteoarthritic cartilage cDNA libraries. Osteoarthritis Cartilage 2001; 9:641-653.
23. Aigner T, Zien A, Gehrsitz A, Gebhard PM, McKenna L. Anabolic and catabolic gene expression pattern analysis in normal versus osteoarthritic cartilage using complementary DNA-array technology. Arthritis Rheum 2001; 44:2777-2789.
24. Stokes DG, Liu G, Coimbra IB, Piera-Velazquez S, Crowl RM, Jimenez SA. Assessment of the gene expression profile of differentiated and dedifferentiated human fetal chondrocytes by microarray analysis. Arthritis Rheum 2002;46:404-419.
25. Aigner T, Saas J, Zien A, Zimmer R, Gebhard P, Knorr T. Analysis of differential gene expression in healthy and osteoarthritic cartilage and isolated chondrocytes by microarray analysis. In Sabatini M, Pastoureau P, De Ceuninck F (Eds.), Cartilage and Osteoarthritis, vol. 1, Cellular and Molecular Methods. Totowa, NJ: Humana Press. Methods Mol Med 2004;100:109-127.
26. Freyria AM, Ronziere MC, Boutillon MM, Herbage D. Two-dimensional electrophoresis of intracellular and secreted protein synthesized by fetal bovine chondrocytes in high-density culture. Electrophoresis 1995;16: 1268-1272.
27. Smith MA, Bains SK, Betts JC, Choy EHS, Zanders ED. Use of two-dimensional gel electrophoresis to measure changes in synovial fluid proteins from patients with rheumatoid arthritis treated with antibody to CD4. Clin Diagn Lab Immunol 2001;8:105-111.
28. Sinz A, Bantscheff M, Mikkat S, et al. Mass spectrometric proteome analyses of synovial fluids and plasmas from patients suffering from rheumatoid arthritis and comparison to reactive arthritis or osteoarthritis. Electrophoresis 2002;23:3445-3456.
29. Yamagiwa H, Sarkar G, Charlesworth MC, McCormick DJ, Bolander ME. Two-dimensional gel electrophoresis of synovial fluid: Method for detecting candidate protein markers for osteoarthritis. J Orthop Sci 2003;8:482-490.
30. Lorenz P, Ruschpler P, Koczan D, Stiehl P, Thiesen HJ. From transcriptome to proteome: Differentially expressed proteins identified in synovial tissue of patients suffering from rheumatoid arthritis and osteoarthritis by an initial screen with a panel of 791 antibodies. Proteomics 2003; 3:991-1002.
31. Shevchenko A, Wilm M, Vorm O, Mann M. Mass spectrometric sequencing of proteins from silver stained polyacrylamide gels. Anal Chem 1996;68:850-858.
32. Zipfel PF, Skerka C, Hellwage, et al. Factor H family proteins: On complement, microbes and human diseases. Biochem Soc Trans 2002;30:971-978.
33. Baer R. TAL 1, TAL2 and LYL1: A family of basic helixloop-helix proteins implicated in T cell acute leukaemia. Semin Cancer Biol 1993;4:341-347.
34. Hansen TM. Biochemical markers in RA. Nord Med 1994;109:228-229.
35. Woo P, O'Brien J, Robson M, Ansell BM. A genetic marker for systemic amyloidosis in juvenile arthritis. Lancet 1987;2:767-769.
36. Hawkins PN, Richardson S, Vigushin DM, et al. Serum amyloid P component scintigraphy and turnover studies for diagnosis and quantitative monitoring of AA amyloidosis in juvenile rheumatoid arthritis. Arthritis Rheum 1993;36:842-851.
37. Friman C, Pettersson T. Amyloidosis. Curr Opin Rheumatol 1996;8:62-71.
38. Connor JR, Kumar S, Sathe G, et al. Clusterin expression in adult human normal and osteoarthritic articular cartilage. Osteoarthritis Cartilage 2001;9:727-737.
39. Boggs LN, Fuson KS, Baez M, et al. Clusterin (Apo J) protects against in vitro amyloid-β(1-40) neurotoxicity. J Neurochem 1996;67:1324-1327.
40. Bickerstaff MC, Botto M, Hutchinson WL, et al. Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity. Nature Med 1999;5:694-697.
41. Quan GMY, Ojaimi J, Nadesapillai APW, Zhou H, Choong PFM. Resistance of epiphyseal cartilage to invasion by osteosarcoma is likely to be due to expression of antiangiogenic factors. Pathobiology 2003;70: 361-367.
42. Chidwick K, Winyard PG, Zhang Z, Farrell AJ, Blake DR. Inactivation of the elastase inhibitory activity of alpha 1 antitrypsin in fresh samples of synovial fluid from patients with rheumatoid arthritis. Ann Rheum Dis 1991;50:915-916.
43. Alsalameh S, Mattka B, Al-Ward R, et al. Preferential expression of tumor necrosis factor receptor 55 (TNFR55) on human articular chondrocytes: Selective transcriptional upregulation of TNF-R75 by proinflammatory cytokines interleukin 1-beta, tumor necrosis factor-alpha, and basic fibroblast growth factor. J Rheumatol 1999;26: 645-653.
44. Zhang HG, Xie J, Yang P, et al. Adeno-associated virus production of soluble tumor necrosis factor receptor neutralizes tumor necrosis factor alpha and reduces arthritis. Hum Gene Ther 2000;11:2431-2442
45. Takemura M, Harada A, Mizuno M, Yano K, Yamada Y. Relationship between osteoprotegerin/osteoclastogenesis inhibitory factor concentration in synovial fluid and disease severity in individuals with osteoarthritis of the knee. Metabolism 2001;50:1-2.
46. Nakashima T, Wada T, Penninger JM. RANKL and RANK as novel therapeutic targets for arthritis. Curr Opin Rheumatol 2003;15:280-287.
47. Hu B, Trinh K, Figueira WF, Price PA. Isolation and sequence of a novel chondrocyte protein related to mammalian members of the chitinase protein family. J Biol Chem 1996;271:19415-19420.
48. De Ceuninck F, Gaufillier S, Bonnaud A, Sabatini M, Lesur C, Pastoureau P. YKL-40 (cartilage gp-39) induces proliferation of cultured chondrocytes and synoviocytes and increases glycosaminoglycan synthesis by chondrocytes. Biochem Biophys Res Commun 2001;285:926-931.
49. Bentz H, Nathan RM, Rosen DM, et al. Purification and characterization of a unique osteoinductive factor from bovine bone. J Biol Chem 1989;264:20805-20810.
50. Erickson GR, Northrup DL, Guilak F. Hypo-osmotic stress induces calcium-dependent actin reorganization in articular chondrocytes. Osteoarthritis Cartilage 2003;11: 187-197.
51. Venn M, Maroudas A. Chemical composition and swelling of normal and osteoarthrotic femoral head cartilage. I. Chemical composition. Ann Rheum Dis 1977;36:121-129.
52. Tkahara K, Kessler E, Biniaminov L, et al. Type I procollagen COOH-terminal proteinase enhancer protein: Identification, primary structure, and chromosomal localization of the cognate human gene (PCOLCE). J Biol Chem 1994;269:26280-26285.
53. Ertenli I, Kiraz S, Ozturk MA, Haznedaroglu I, Celik I, Calguneri M. Pathologic thrombopoiesis of rheumatoid arthritis. Rheumatol Int 2003;23:49-60.